68 related articles for article (PubMed ID: 10401041)
1. Rapidly developing T-cell posttransplantation lymphoproliferative disorder.
Kim JY; Kim CW; Ahn C; Bang YJ; Lee HS
Am J Kidney Dis; 1999 Jul; 34(1):e3. PubMed ID: 10401041
[TBL] [Abstract][Full Text] [Related]
2. Detection of Epstein-Barr virus DNA in sequential renal transplant biopsy specimens using the polymerase chain reaction. Report of a patient with a posttransplant lymphoproliferative disorder.
Lager DJ; Slagel DD; Burgart LJ
Arch Pathol Lab Med; 1993 Mar; 117(3):308-12. PubMed ID: 8382918
[TBL] [Abstract][Full Text] [Related]
3. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
[TBL] [Abstract][Full Text] [Related]
4. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
6. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
7. T-cell acute lymphoblastic leukemia after renal transplantation in childhood.
Levendoglu-Tugal O; Weiss R; Ozkaynak MF; Sandoval C; Lentzner B; Jayabose S
J Pediatr Hematol Oncol; 1998; 20(6):548-51. PubMed ID: 9856676
[TBL] [Abstract][Full Text] [Related]
8. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
Abu-Farsakh H; Cagle PT; Buffone GJ; Bruner JM; Weilbaecher D; Greenberg SD
Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder.
Lager DJ; Burgart LJ; Slagel DD
Mod Pathol; 1993 Jan; 6(1):42-7. PubMed ID: 8381232
[TBL] [Abstract][Full Text] [Related]
10. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
11. Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature.
Hsi ED; Picken MM; Alkan S
Mod Pathol; 1998 May; 11(5):479-84. PubMed ID: 9619602
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
Rosendale B; Yousem SA
Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient.
Schlieper G; Kurschat C; Donner A; Huckenbeck W; RĂ¼diger T; Sandmann W; Grabensee B; Ivens K; Heering P
Am J Kidney Dis; 2006 Mar; 47(3):e37-41. PubMed ID: 16490613
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
15. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
[TBL] [Abstract][Full Text] [Related]
16. A case of plasmacytic hyperplasia arising in a kidney allograft salvaged with immunosuppression reduction alone.
Harada H; Miura M; Shimoda N; Seki T; Togashi M; Ogawa Y; Takada A; Tahara M; Sato H; Hirano T
Clin Transplant; 2004; 18 Suppl 11():50-3. PubMed ID: 15191374
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
[TBL] [Abstract][Full Text] [Related]
18. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival posttransplantation lymphoproliferative disorder.
Walton RC; Onciu MM; Irshad FA; Wilson TD
Am J Ophthalmol; 2007 Jun; 143(6):1050-1. PubMed ID: 17524778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]